Skip to content

Clinical trials

Phase 1/2 Lung Injury trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Injury Phase: Phase 1/2 Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affiliated Hospital to Academy of Military Medical Sciences1
Cell Energy Life Sciences Group Co. LTD1
Rapa Therapeutics LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Injury3
Acute Lung Injury1
COVID-191
Coronavirus Infections1
Cytokine Release Syndrome1
Lung Diseases1
Pneumonia1
Respiratory Distress Syndrome1

Trials

Showing 51 to 3 of 3. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.